Sino Biopharmaceutical Limited-B (02509.HK) collectively subscribed to 1.2 billion yuan of China Merchants Bank wealth management product.

Financial Channel APP news, Quanxin Biology-B (02509.HK) announced that on July 4, 2025, in order to make effective use of idle funds, the company signed two subscription agreements with Shanghai Pudong Development Bank to subscribe to two wealth management products provided by the bank. The subscription amounts are both 60 million yuan, and the maturity dates are both October 9, 2025.